IWC
LCTX icon

Integrated Wealth Concepts’s Lineage Cell Therapeutics LCTX Stock Holding History

Integrated Wealth Concepts’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,000
Closed -$12K – 1373
2022
Q4 		$12K Buy
+10,000
New +$12.6K ﹤0.01% 1032
2022
Q3 		– Sell
-10,000
Closed -$16K – 985
2022
Q2 		$16K Hold
10,000
– – ﹤0.01% 974
2022
Q1 		$15K Buy
+10,000
New +$15.5K ﹤0.01% 933
2021
Q2 		– Sell
-10,000
Closed -$24K – 821
2021
Q1 		$24K Buy
+10,000
New +$24K ﹤0.01% 731

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return